Magazine Article | November 7, 2018

How To Put A Price Tag On Emerging Therapies

Source: Life Science Leader

By Herman Sanchez & Andrew Combs

There’s no doubt that partnerships and M&As are key growth drivers in the biopharma industry. But for collaborative relationships to occur, understanding the value of a company’s underlying assets is critical.

Forecast and valuation engagements in the life sciences industry have grown following recent venture investment trends. According to Evaluate, between 2012 and 2017, both total investments and average investments per financing event increased by about 20 percent each year.

VIEW THE MAGAZINE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Life Science Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: